A Preview Of Krystal Biotech's Earnings
Portfolio Pulse from Benzinga Insights
Krystal Biotech (NASDAQ:KRYS) is set to release its latest quarterly earnings report on November 6, 2023. Analysts estimate an earnings per share (EPS) of $-0.15. The company's past performance shows a trend of share price increase following earnings reports, even when EPS missed estimates. The stock is currently trading at $119.05 and has seen a 54.63% increase over the last 52-week period.
November 03, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Krystal Biotech is expected to announce its Q3 earnings on November 6, 2023. The company's stock has historically increased following earnings reports, suggesting potential positive short-term impact.
Krystal Biotech's stock has shown a trend of increasing following earnings reports, even when the company missed EPS estimates. This suggests that investors may react positively to the upcoming earnings announcement, potentially driving the stock price up in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100